:

Homeland Security

Briefing

DDN

Wednesday, October 3rd, 2007

SHARE:

*Emergent BioSolutions [EBS] received a $400 million contract from the Department of Health and Human Services (HHS) to provide 18.75 million doses of the anthrax vaccine BioThrax through Sept. 2010 for the strategic national stockpile. Contract terms also include an additional $34 million if the Food and Drug Administration approves the company's pending supplement to its biologics license application to extend the shelf life of BioThrax from three years to four years. On top of all that, HHS will provide…

Congress

Key Defense Committee Members Face Tight Midterm Races, Including HASC GOP’ers In Virginia

As the mid-term elections near with polls showing an increasing likelihood of a switch in majority control in the House and potentially the Senate, three Virginia Republicans on the House […]

‘Theoretical Potential’ to Achieve 1,509 Combat-Coded Fighters by 2035, USAF Says

In the latest U.S. Air Force fighter force structure report submitted to Congress, the service speaks of a “theoretical potential” to achieve a goal of 1,509 combat-coded fighters in the […]

Budget

Hegseth Pushes For Reconciliation With At Least $350 Billion For Defense ‘Regardless’ Of Midterms Outcome

Defense Secretary Pete Hegseth said Wednesday the Trump administration plans to continue its push for at least $350 billion in defense funds via the reconciliation process “regardless of what happens […]

Congress

Bipartisan Push in Senate to Hasten Export of 155 mm, GMLRS, HIMARS for Ukraine

A small, bipartisan group of senators is backing the Fast Tracking European Investment in Ukraine’s Defense Act, S. 5175, to hasten the export of allied buys of U.S. munitions for […]